2020
DOI: 10.1016/j.exphem.2020.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…15 TSGL-Ig was previously shown to prevent ischemiareperfusion injury of orthotopic liver transplants in mice by attenuating leukocyte sequestration in the liver microcirculation, 15 and significantly attenuated intravenous oxy-hemoglobin triggered lung vasoocclusion in sickle cell disease mice. 16 We demonstrated that SELPLG promoter activity increases with LPS and mechanical stretch. Through serial progressive 5′ to 3′ unidirectional deletions and promoter activity assays, we identified possible SELPLG promoter regions that might affect basic and LPSinduced enhanced SELPLG transcription activities.…”
Section: Discussionmentioning
confidence: 75%
See 4 more Smart Citations
“…15 TSGL-Ig was previously shown to prevent ischemiareperfusion injury of orthotopic liver transplants in mice by attenuating leukocyte sequestration in the liver microcirculation, 15 and significantly attenuated intravenous oxy-hemoglobin triggered lung vasoocclusion in sickle cell disease mice. 16 We demonstrated that SELPLG promoter activity increases with LPS and mechanical stretch. Through serial progressive 5′ to 3′ unidirectional deletions and promoter activity assays, we identified possible SELPLG promoter regions that might affect basic and LPSinduced enhanced SELPLG transcription activities.…”
Section: Discussionmentioning
confidence: 75%
“…Spontaneously breathing (SB) control mice received intratracheal PBS instead of LPS and following 18 h period, allowed to breathe spontaneously on room air (SB) for 4 h before harvesting. TSGL-Ig (1 mg/Kg), a novel recombinant tandem PSGL1 immunoglobulin fusion molecule which is a competitive inhibitor of PSGL1/P-selectin interactions 15,16 was delivered intravenously concomitantly with LPS challenge before initiation of VILI.…”
Section: Lps/vili "Two-hit" Preclinical Ards Mouse Model and Delivery...mentioning
confidence: 99%
See 3 more Smart Citations